Literature DB >> 15750198

Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma.

Wei Li1, Ru-jun Xu, Li-hui Jiang, Jingfeng Shi, Xiang Long, Bei Fan.   

Abstract

The present study evaluated the significance of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in 30 patients with endometrial carcinoma and the relationship of those molecular markers to tumor characteristics and microvessel density (MVD). Immunohistochemical expression of COX-2, iNOS, and CD34 was analyzed on paraffin-embedded tissue sections. The COX-2 and iNOS positive rates were 66.7% and 73.3%, respectively. The level of COX-2 expression was higher in grade II tumors than in grade III tumors (p < 0.05). The percentage of iNOS positivity was higher in patients with deep myometrial invasion than in patients without or less than 50% myometrial invasion (p < 0.05). There was significant correlation between positive COX-2 and positive iNOS expression (r = 0.601, p < 0.001). Both COX-2 and iNOS were significantly correlated with MVD (r = 0.02 p < 0.05; r = 0.599 p < 0.0001, respectively). The present findings suggest that combined expression of COX-2 and iNOS may play an important role in development and invasion of endometrial cancer and that this could be partially attributable to modulation of angiogenesis by COX-2 and iNOS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750198     DOI: 10.1385/MO:22:1:063

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  42 in total

Review 1.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

2.  Expression of cyclo-oxygenase in human endometrium during the implantation period.

Authors:  L Marions; K G Danielsson
Journal:  Mol Hum Reprod       Date:  1999-10       Impact factor: 4.025

3.  Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.

Authors:  M Krajewska; S Krajewski; J I Epstein; A Shabaik; J Sauvageot; K Song; S Kitada; J C Reed
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

4.  Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue.

Authors:  M Kojima; T Morisaki; Y Tsukahara; A Uchiyama; Y Matsunari; R Mibu; M Tanaka
Journal:  J Surg Oncol       Date:  1999-04       Impact factor: 3.454

Review 5.  Role of nitric oxide in tumour progression: lessons from human tumours.

Authors:  L L Thomsen; D W Miles
Journal:  Cancer Metastasis Rev       Date:  1998-03       Impact factor: 9.264

6.  Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment.

Authors:  S Madaan; P D Abel; K S Chaudhary; R Hewitt; M A Stott; G W Stamp; E N Lalani
Journal:  BJU Int       Date:  2000-10       Impact factor: 5.588

7.  Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.

Authors:  R Fujiwaki; K Hata; K Iida; Y Maede; Y Watanabe; M Koike; K Miyazaki
Journal:  Acta Obstet Gynecol Scand       Date:  1999-09       Impact factor: 3.636

8.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

Authors:  H Sano; Y Kawahito; R L Wilder; A Hashiramoto; S Mukai; K Asai; S Kimura; H Kato; M Kondo; T Hla
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

9.  Nitric oxide synthase activity in human gynecological cancer.

Authors:  L L Thomsen; F G Lawton; R G Knowles; J E Beesley; V Riveros-Moreno; S Moncada
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

10.  Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

Authors:  M Ziche; L Morbidelli; E Masini; S Amerini; H J Granger; C A Maggi; P Geppetti; F Ledda
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

View more
  9 in total

1.  MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma.

Authors:  Ying Liu; Haiyan Li; Congying Zhao; Hanbing Jia
Journal:  Mol Cell Biochem       Date:  2018-02-05       Impact factor: 3.396

2.  Effect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo.

Authors:  Wei Li; Mei-Lin Liu; Jia-Hui Cai; Yun-Xian Tang; Ling-Yun Zhai; Jun Zhang
Journal:  Oncol Lett       Date:  2012-04-23       Impact factor: 2.967

3.  Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice.

Authors:  Wei Li; Zhong-lei Ji; Guang-chao Zhuo; Ru-jun Xu; Jie Wang; Hong-ru Jiang
Journal:  Med Oncol       Date:  2009-02-24       Impact factor: 3.064

4.  Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.

Authors:  Wei Li; Ru-Jun Xu; Zhen-Yun Lin; Guang-Chao Zhuo; Hong-He Zhang
Journal:  Med Oncol       Date:  2008-11-06       Impact factor: 3.064

5.  Effects of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of ovarian carcinoma in vivo.

Authors:  Wei Li; Hong-he Zhang; Ru-jun Xu; Guang-chao Zhuo; Ye-qing Hu; Juan Li
Journal:  Med Oncol       Date:  2007-10-06       Impact factor: 3.064

6.  Proteomic Analysis of Endometrial Cancer Tissues from Patients with Type 2 Diabetes Mellitus.

Authors:  Muhammad Mujammami; Mohamed Rafiullah; Assim A Alfadda; Khalid Akkour; Ibrahim O Alanazi; Afshan Masood; Mohthash Musambil; Hani Alhalal; Maria Arafah; Anas M Abdel Rahman; Hicham Benabdelkamel
Journal:  Life (Basel)       Date:  2022-03-28

7.  Production of nitric oxide and expression of inducible nitric oxide synthase in ovarian cystic tumors.

Authors:  Rosekeila Simões Nomelini; Lívia Carolina de Abreu Ribeiro; Beatriz Martins Tavares-Murta; Sheila Jorge Adad; Eddie Fernando Candido Murta
Journal:  Mediators Inflamm       Date:  2009-01-05       Impact factor: 4.711

8.  Dietary administration of Nexrutine inhibits rat liver tumorigenesis and induces apoptotic cell death in human hepatocellular carcinoma cells.

Authors:  Shamshad Alam; Ravi S Yadav; Anu Pal; Shakendra K Purshottam; Bhushan P Chaudhari; Mukul Das; Kausar M Ansari
Journal:  Toxicol Rep       Date:  2014-11-13

9.  Prospects of NSAIDs administration as double-edged agents against endometrial cancer and pathological species of the uterine microbiome.

Authors:  Olga Kuźmycz; Paweł Stączek
Journal:  Cancer Biol Ther       Date:  2020-03-15       Impact factor: 4.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.